General Information of This Antigen (ID: TAR0WBVOL)
Antigen Name
Glypican-1 (GPC1)
Gene Name
GPC1
Gene ID
2817
Sequence
MELRARGWWLLCAAAALVACARGDPASKSRSCGEVRQIYGAKGFSLSDVPQAEISGEHLR
ICPQGYTCCTSEMEENLANRSHAELETALRDSSRVLQAMLATQLRSFDDHFQHLLNDSER
TLQATFPGAFGELYTQNARAFRDLYSELRLYYRGANLHLEETLAEFWARLLERLFKQLHP
QLLLPDDYLDCLGKQAEALRPFGEAPRELRLRATRAFVAARSFVQGLGVASDVVRKVAQV
PLGPECSRAVMKLVYCAHCLGVPGARPCPDYCRNVLKGCLANQADLDAEWRNLLDSMVLI
TDKFWGTSGVESVIGSVHTWLAEAINALQDNRDTLTAKVIQGCGNPKVNPQGPGPEEKRR
RGKLAPRERPPSGTLEKLVSEAKAQLRDVQDFWISLPGTLCSEKMALSTASDDRCWNGMA
RGRYLPEVMGDGLANQINNPEVEVDITKPDMTIRQQIMQLKIMTNRLRSAYNGNDVDFQD
ASDDGSGSGSGDGCLDDLCSRKVSRKSSSSRTPLTHALPGLSEQEGQKTSAASCPQPPTF
LLPLLLFLALTVARPRWR

    Click to Show/Hide
Family
Glycosyltransferase 32 family
Function
Cell surface proteoglycan that bears heparan sulfate. Binds, via the heparan sulfate side chains, alpha-4 (V) collagen and participates in Schwann cell myelination. May act as a catalyst in increasing the rate of conversion of prion protein PRPN(C) to PRNP(Sc) via associating (via the heparan sulfate side chains) with both forms of PRPN, .geting them to lipid rafts and facilitating their interaction. Required for proper skeletal muscle differentiation by sequestering FGF2 in lipid rafts preventing its binding to receptors (FGFRs) and inhibiting the FGF-mediated signaling.

    Click to Show/Hide
Uniprot Entry
GPC1_HUMAN
HGNC ID
HGNC:4449
KEGG ID
hsa:2817
Each Antibody-drug Conjugate and Its Component Related to This Antigen
Full List of The ADC Related to This Antigen
The Numbers of ADCs, Their Three Components, Payload Targets, and Corresponding Diseases for This Antigens
Anti-GPC1 GPC1-ADC (MMAE) mAb
ADC Name Payload Target Linker ADC Info
GPC1-ADC-MMAE [1]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-GPC1 GPC1-ADC mAb
ADC Name Payload Target Linker ADC Info
GPC1-ADC-MMAF [2]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-GPC1 mAb 01a002
ADC Name Payload Target Linker ADC Info
GPC-1 ADC 2 [3]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-GPC1 mAb 01a007
ADC Name Payload Target Linker ADC Info
GPC-1 ADC 15 [3]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-GPC1 mAb 01a009
ADC Name Payload Target Linker ADC Info
GPC-1 ADC 12 [3]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-GPC1 mAb 01a016
ADC Name Payload Target Linker ADC Info
GPC-1 ADC 8 [3]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-GPC1 mAb 01a017
ADC Name Payload Target Linker ADC Info
GPC-1 ADC 14 [3]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-GPC1 mAb 01a021
ADC Name Payload Target Linker ADC Info
GPC-1 ADC 10 [3]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-GPC1 mAb 01a026
ADC Name Payload Target Linker ADC Info
GPC-1 ADC 17 [3]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-GPC1 mAb 01a030
ADC Name Payload Target Linker ADC Info
GPC-1 ADC 13 [3]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-GPC1 mAb 01a033
ADC Name Payload Target Linker ADC Info
GPC-1 ADC 1 [3]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-GPC1 mAb 01a042
ADC Name Payload Target Linker ADC Info
GPC-1 ADC 16 [3]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-GPC1 mAb 02a002
ADC Name Payload Target Linker ADC Info
GPC-1 ADC 6 [3]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-GPC1 mAb 02a006
ADC Name Payload Target Linker ADC Info
GPC-1 ADC 18 [3]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-GPC1 mAb 02a010
ADC Name Payload Target Linker ADC Info
GPC-1 ADC 7 [3]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-GPC1 mAb 02a014
ADC Name Payload Target Linker ADC Info
GPC-1 ADC 5 [3]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-GPC1 mAb 02a022
ADC Name Payload Target Linker ADC Info
GPC-1 ADC 11 [3]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-GPC1 mAb 02a034
ADC Name Payload Target Linker ADC Info
GPC-1 ADC 4 [3]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-GPC1 mAb 02a035
ADC Name Payload Target Linker ADC Info
GPC-1 ADC 3 [3]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-GPC1 mAb 02b006
ADC Name Payload Target Linker ADC Info
GPC-1 ADC 9 [3]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-GPC1 mAb clone 01a033
ADC Name Payload Target Linker ADC Info
GPC-1-ADC [4]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
humanized anti-GPC1 monoclonal antibody
ADC Name Payload Target Linker ADC Info
GPC1-ADC [5]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
References
Ref 1 A glypican-1-targeted antibody-drug conjugate exhibits potent tumorgrowth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma. Neoplasia. 2021 Sep;23(9):939-950.
Ref 2 Anti-Glypican-1 Antibody-drug Conjugate as Potential Therapy Against Tumor Cells and Tumor Vasculature for Glypican-1-Positive Cholangiocarcinoma. Mol Cancer Ther. 2021 Sep;20(9):1713-1722. doi: 10.1158/1535-7163.MCT-21-0015. Epub 2021 Jun 17.
Ref 3 Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer. Int J Cancer. 2018 Mar 1;142(5):1056-1066. doi: 10.1002/ijc.31124. Epub 2017 Oct 31.
Ref 4 Anti-glypican-1 antibody-drug conjugate is a potential therapy against pancreatic cancer. Br J Cancer. 2020 Apr;122(9):1333-1341. doi: 10.1038/s41416-020-0781-2. Epub 2020 Mar 10.
Ref 5 Assessing efficacy of anti-glypican-1antibody-drug conjugate as potential therapeutic approach for gastric cancer